Functional: Pharmacological Management of LUTS: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 355: | Line 355: | ||
** Only silodosin showed a significant effect on nocturia over placebo. | ** Only silodosin showed a significant effect on nocturia over placebo. | ||
===== | ===== Adverse events ===== | ||
* '''<span style="color:#ff0000">Most common (5):</span>''' | * '''<span style="color:#ff0000">Most common (5):</span>''' | ||
| Line 405: | Line 405: | ||
*# '''Gynecomastia''' (2%) | *# '''Gynecomastia''' (2%) | ||
===== | ===== Other benefits of 5-ARIs (4): ===== | ||
# '''Improves sensitivity of PSA and DRE for prostate cancer detection''' | # '''Improves sensitivity of PSA and DRE for prostate cancer detection''' | ||
# '''Reduced risk of prostatitis''' | # '''Reduced risk of prostatitis''' | ||
| Line 439: | Line 439: | ||
** Initial reports of the use of intravesical prostanoids producing lasting favorable clinical effects have not been confirmed. | ** Initial reports of the use of intravesical prostanoids producing lasting favorable clinical effects have not been confirmed. | ||
=== | === Phytotherapy === | ||
* '''Saw palmetto''' | * '''Saw palmetto''' | ||
** RCT | ** RCT | ||